Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Intramural Hematoma and “Cuttering” as a Rescue Technique

Coronary dissections can be self-limiting or they can progress, generating an intramural hematoma (IMH). The false lumen resulting from the dissection can expand, increasing endoluminal pressure and compressing the true lumen, which reduces distal antegrade flow.

Hematoma intramural y “cuttering” como técnica de rescate

When dissections or hematomas are limited and do not affect the blood flow, the usual recommendation is conservative management. However, cases with compromised distal flow require interventions. These can be complex due to the difficulty of navigating the true lumen and the limitations of contrast use due to dissection progression. In some cases, there may be a need for techniques typically used for chronic total occlusion (CTO) recanalization, such as subintimal tracking and reentry, fenestration and reentry, or specific devices like the Stingray system or intravascular ultrasound (IVUS)-guided reentry.

Containing the IMH expansion is crucial. Case reports and series have suggested the use of cutting balloons (CB) for its management. Typically, operators select cutting balloons slightly smaller or equivalent (1:1) to the reference vessel diameter, which are inflated to nominal pressure to create fenestrations between the false and true lumen, thus relieving endoluminal pressure. 

In certain cases, conventional use of CB may be insufficient, and the hematoma progresses distally. This work aimed to present the initial results for an innovative technique called “Cuttering” (Cutting-Dottering Balloon). 

Read also: Angiography-Derived Index of Microvascular Resistance and its Prognostic Value in Patients with NSTEMI.

A CB 1:1 to the reference vessel is advanced to the area of maximum lumen compression. It is inflated to its nominal pressure (6-9 atm) followed by subtle back-and-forth movements. If sliding is difficult, the balloon can be inflated partially at less atm, and multiple inflations may also be used.

Procedural success can be visually assessed via angiography or IVUS, observing changes in blood speckle intensity. In this study, the team from Humanitas Research Hospital and Ospedale Papa Giovanni XXIII (Italy) presented results from the first patients treated with this technique. 

The benefits of the Cuttering technique include concentrated force during sliding movements, progressive cutting, and the formation of microfractures. While the use of CB alone can restore TIMI III flow, in cases where this result is not achieved, the Cuttering technique may increase the chances of success. 

Read also: Failed Thrombus Aspiration in STEMI, and Impact.

In this small case series, restoration of TIMI III flow was achieved in 5 of the 7 treated patients, while the other two achieved TIMI II flow, with no significant clinical sequelae. The authors discourage the use of the Cuttering technique in calcified lesions or vessels with severe tortuosity due to the risk of perforation or serious vessel damage.

Conclusions

In cases where conventional inflation with cutting balloons is insufficient for the treatment of intramural hematoma, the Cuttering technique could be a viable option for hematoma drainage and coronary flow improvement.

Original Title: The “Cuttering (Cutting‐Dottering Balloon) Technique” for treatment of flow‐limiting coronary intramural hematoma.

Reference: Gasparini GL, Maurina M, Regazzoli D, Canova P, Leone PP, Mangieri A, Reimers B. The “Cuttering (Cutting-Dottering Balloon) Technique” for treatment of flow-limiting coronary intramural hematoma. Catheter Cardiovasc Interv. 2024 Sep 26. doi: 10.1002/ccd.31231. Epub ahead of print. PMID: 39323300.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...